← Leaderboards
Kendra Elizabeth Wulczyn
Massachusetts General Hospital
$329,778
Attributed
$329,778
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $199.1K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$329,778 · 2
By mechanism
K23$199,130 · 1
F32$130,648 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Vitaly Napadow$23,761,421
- Virginia Athena Triant$9,524,641
- Alisa Knodle Manning$6,996,063
- Brent K. Hollenbeck$12,084,917
- Allen C Steere$11,999,334
Others in their field
Other Rising Stars on “Patient Population”
- Jeffrey Leintz · National Opinion Research Center$40,628,545
- Suma Babu · Massachusetts General Hospital$34,837,233
- Sabrina Paganoni · Massachusetts General Hospital$34,837,233
- Jinsy Andrews · Columbia University Health Sciences$21,294,649
- Daniel Hunter Reirden · Westat, Inc.$16,121,731
- Maximilian Haeussler · University Of California Santa Cruz$12,592,563
Research focus
Patient PopulationResearch MethodologyKidneyParticipantPsyche StructureReportingCohortHealth Related Quality Of LifeMentorsMortalityPerformancePredictive ModelingQuality Of LifeCessation Of LifeAdultChronic Kidney FailureChronic Kidney InsufficiencyAwardClinical Decision-MakingKidney DiseasesClinical PracticeBiometryDialysis ProcedureSkills
Grant awards (3)
Patient-Reported Outcome Measure (PROM) Utilization to Advance Patient Centered CKD Care$199,130
K23 · FY2025 · DK · contact PI
Determinants of Uremic Symptoms in CKD and Associations to Clinical Outcomes$47,402
F32 · FY2023 · DK · contact PI
Determinants of Uremic Symptoms in CKD and Associations to Clinical Outcomes$83,246
F32 · FY2022 · DK · contact PI